Welcome to our dedicated page for Viavi Solutions SEC filings (Ticker: VIAV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Viavi Solutions Inc. (NASDAQ: VIAV) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures alongside AI‑generated summaries. As a global provider of network test, monitoring and assurance solutions and optical security and light management technologies, VIAVI uses its SEC reports to describe its segment performance, capital structure, governance and material events.
Investors can review annual reports on Form 10‑K and quarterly reports on Form 10‑Q for detailed information on the Network and Service Enablement and Optical Security and Performance Products segments, geographic revenue breakdowns, risk factors and management’s discussion and analysis. Current reports on Form 8‑K document significant developments such as the completion of the acquisition of Spirent Communications plc’s high-speed ethernet, network security and channel emulation testing business, entry into term loan and revolving credit agreements, issuance and exchange of Senior Convertible Notes, and share exchange transactions.
This page also surfaces filings related to corporate governance and shareholder matters, including the definitive proxy statement (DEF 14A) for the annual meeting of stockholders and amendments to the certificate of incorporation. Where applicable, Form 3, 4 and 5 insider transaction reports can be used to track trading activity by directors and officers.
Stock Titan’s AI features help interpret lengthy documents by highlighting key terms such as segment revenue trends, leverage and debt instruments, equity incentive plans, and amendments to governance documents. Real‑time updates from EDGAR ensure that new VIAV filings, from earnings‑related 8‑Ks to financing agreements, appear promptly with concise explanations of their significance.
VIAVI Solutions (VIAV) reported a director equity award on a Form 4. On 11/13/2025, the reporting person received 14,369 restricted stock units (RSUs) at a price of $0, representing the right to receive the same number of shares of common stock.
The RSUs vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders. The filing notes that RSUs have no expiration date. Following the transaction, the reporting person held 14,369 derivative securities directly, each underlying one share of common stock.
VIAVI Solutions (VIAV) director reported a grant of 14,369 restricted stock units (RSUs) on 11/13/2025, according to a Form 4 filing. The units vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders. Following the transaction, 14,369 derivative securities were beneficially owned, with ownership reported as direct.
Viavi Solutions (VIAV) director reported an equity award of 14,369 restricted stock units (RSUs) on 11/13/2025. Each RSU is tied to one share of common stock.
The RSUs vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders. The filing notes there are no expiration dates on RSUs.
Following the reported transaction, the director’s beneficially owned derivative securities total 14,369, held directly.
Viavi Solutions (VIAV) filed a Form 4 reporting a director’s grant of 14,369 restricted stock units (RSUs) on 11/13/2025 at a price of $0. Following the grant, the director beneficially owns 14,369 shares directly.
The RSUs vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders. The RSUs have no expiration date.
Viavi Solutions (VIAV)14,369 restricted stock units (RSUs) on November 13, 2025 at a price of $0.
The RSUs will vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders, and RSUs have no expiration date. Following the transaction, 14,369 derivative securities are beneficially owned, reported as direct ownership. Each RSU represents a right to receive one share of common stock upon vesting.
Viavi Solutions (VIAV) reported an insider equity award. A director received 14,369 restricted stock units (RSUs) on 11/13/2025 at a stated price of $0. The RSUs are scheduled to vest on the earlier of the one-year anniversary of grant or the next Annual Meeting of Stockholders. Following the transaction, the reporting person beneficially owned 14,369 derivative securities, held directly. RSUs have no expiration date.
Viavi Solutions (VIAV) reported an insider equity award on Form 4. A director acquired 14,369 restricted stock units (RSUs) on 11/13/2025 at a reported price of $0.
The RSUs cover 14,369 shares of common stock and will vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders. The filing notes there are no expiration dates on RSUs. The position is reported as direct ownership.
Viavi Solutions (VIAV) disclosed a director equity grant on Form 4. On 11/13/2025, the reporting person received 14,369 restricted stock units (transaction code A) at $0. The RSUs vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders, and RSUs carry no expiration. After the transaction, 14,369 derivative securities were beneficially owned directly.
Viavi Solutions (VIAV) insider activity: A company director reported two open-market sales of common stock on 11/10/2025. The transactions included 23,529 shares sold at a weighted average price of $18.22 and 97,938 shares sold at a weighted average price of $18.17. Following these sales, the reporting person directly beneficially owned 27,213 shares. The filing notes that trades were executed in multiple transactions within the stated price ranges, and full trade details are available upon request.
Viavi Solutions (VIAV) reported an insider equity change by a director. On November 7, 2025, restricted stock units vested and converted into 23,529 shares of common stock at $0 per share (transaction code M). Following the settlement, the director directly holds 142,497 shares.
The RSUs convert one-for-one into common stock and vested 100% on November 7, 2025; the reported RSU balance from this grant is now 0. The filing does not show any share sales.